این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Research in Pharmaceutical Sciences، جلد ۲۰، شماره ۴، صفحات ۵۱۱-۵۲۳
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی In silico prediction of paradoxical effect for oxaliplatin in gastric cancer patients based on their transcriptomic profile
چکیده انگلیسی مقاله Background and purpose: Gastric cancer (GC) is a major global health concern, ranking as the fifth most commonly diagnosed cancer. New treatment strategies like chemoprevention with oxaliplatin (OXA) are emerging, but safety data for GC patients are limited. This in silico study aimed to predict potential paradoxical effects of OXA treatment in GC patients using computational analysis. Experimental approach: RNA-sequencing data from GSE26942, GSE66229, and TCGA-STAD datasets were analyzed. Differential gene expression was identified using GEO2R and DESeq2. Pathway enrichment and protein-protein interaction networks were constructed to pinpoint genes crucial for GC progression. Finally, the R Survival package identified survival-related differentially expressed genes (DEGs). Interactions between OXA and GC-related genes were retrieved from the CTD database and compared with DEGs. Findings/Results: A total of 151 dysregulated genes were identified across the datasets, comprising 112 downregulated and 39 upregulated genes. Thirteen genes emerged as potential prognostic biomarkers for overall survival. OXA interacted with 97 genes, of which 14 were linked to both OXA and differentially expressed genes in GC. OXA potentially reversed the expression of seven genes associated with GC progression (BIRC5, CAV1, CDH2, IL6, JUN, SERPINB2, TYMS), while promoting the expression of six others (BLVRB, CDKN2A, MAPK3, PLAU, PTGS2, SERPINE1). Notably, SERPINE1 showed a strong correlation with overall survival. Conclusion and implications: Our findings suggest that a patient's genetic profile, particularly SERPINE1 expression levels, might be crucial for determining the safety and efficacy of OXA treatment for GC.    
کلیدواژه‌های انگلیسی مقاله Chemoprevention,Oxaliplatin,Stomach cancer,SERPINE1,Cancer Genome Atlas (TCGA).
نویسندگان مقاله | Fatemeh Khara
Department of Medical Genetics, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.


| Atefeh Heydari
Department of Genetics and Molecular Biology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.


| Mahmood Fadaie
Department of Genetics and Molecular Biology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.


| Anis Khalafiyan
Department of Genetics and Molecular Biology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.


| Hossein Khanahmad


نشانی اینترنتی http://rps.mui.ac.ir/index.php/jrps/article/view/2324
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Original Article
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات